Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2012

View Archived Issues

Health Canada approves line extension for Prevnar 13

Bioheart gains worldwide rights to adipose stem cell technology

Novel MAP kinase p38 alpha inhibitors synthesized at Amgen

BioCryst reports preclinical data on BCX-5191

Adeona Pharmaceuticals changes name

Arno Therapeutics and Invivis Pharmaceuticals sign licensing agreement

GSK withdraws indication extension application for Tyverb

German marketing collaboration signed for Vitaros

Novartis Vaccines and Diagnostics withdraws MAA for Fluad Pediatric

New aldose reductase inhibitors designed in U.S.

New GSNOR inhibitors and tachykinin NK3 receptor antagonists patented

Genetadi Biotech presents novel integrin alpha-V/beta-3 ligands

Takeda reports novel NF-kappa-B activation inhibitors

Japanese and Spanish university jointly develop new beta-amyloid production inhibitors

Novel candidate analgesics prepared at Pfizer

Chinese company divulges new GPR119 receptor agonists and DPP IV inhibitors

Collaborating U.S. universities identify new monoamine reuptake inhibitors

FDA accepts Uceris NDA

New beta-amyloid production inhibitors discovered at Bristol-Myers Squibb

UCB planning regulatory applications for Cimzia in new indication

Study reveals mode of action of influenza-inhibiting NME

New analgesic is potent and not addictive

BioMarin begins clinical testing of achondroplasia candidate

Ongoing phase III trials of NX-1207 show no safety concerns

Roche obtains Canadian approval for Zelboraf

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...